In vitro antiseptic susceptibilities for Staphylococcus pseudintermedius isolated from canine superficial pyoderma in Japan

Veterinary Dermatology

Volumn 24, Issue 1, 2013, Pages

  Murayama, Nobuo ^a   Nagata, Masahiko ^a   Terada, Yuri ^a   Okuaki, Mio ^a   Takemura, Noriyuki ^b   Nakaminami, Hidemasa ^b   Noguchi, Norihisa ^b  

^a ASC Dermatology Service   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; JAPAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PYODERMA; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DOGS; GENE EXPRESSION REGULATION, BACTERIAL; JAPAN; MICROBIAL SENSITIVITY TESTS; PYODERMA; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS PSEUDINTERMEDIUS;

EID: 84872735697     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2012.01103.x     Document Type: Article

References (33)

1. Sasaki T, Kikuchi K, Tanaka Y et al. Reclassification of phenotypically identified Staphylococcus intermedius strains. J Clin Microbiol 2007; 45: 2770-2778.
2. Nagata M, Murayama N, Shibata K. Efficacy of Nolvasan Surgical Scrub containing 2% chlorhexidine acetate in topical management of canine superficial pyoderma: a randomized, double-blinded, controlled study. Jpn J Vet Dermatol 2006; 12: 1-6.
3. Murayama N, Nagata M, Terada Y et al. Efficacy of a surgical scrub including 2% chlorhexidine acetate for canine superficial pyoderma. Vet Dermatol 2010; 21: 586-592.
4. Murayama N, Terada Y, Okuaki M et al. Dose assessment of 2% chlorhexidine acetate for canine superficial pyoderma. Vet Dermatol 2011; 22: 449-453.
5. Pearman JW, Christiansen KJ, Annear DI et al. Control of methicillin-resistant Staphylococcus aureus (MRSA) in an Australian metropolitan teaching hospital complex. Med J Aust 1985; 21: 103-108.
6. Lee AS, Macedo-Vinas M, Francois P et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococus aureus carriage after decolonization: a case-control study. Clin Infect Dis 2011; 52: 1422-1430.
7. McDonnell G, Russell AD. Antiseptic and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999; 12: 147-179.
8. Alam MH, Kobayashi N, Uehara N et al. Analysis on distribution and genomic diversity of high-level antiseptic resistance genes qacA and qacB in human clinical isolates of Staphylococcus aureus. Microb Drug Resist 2003; 9: 109-121.
9. Mitchell BA, Brown MH, Skurray R. QacA multidrug efflux pump from Staphylococcus aureus: comparative analysis of resistance to diamidines, biguanidines, and guanylhydrazones. Antimicrob Agents Chemother 1998; 42: 475-477.
10. Tennent JM, Lyon BR, Midgley M et al. Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. J Gen Microbiol 1989; 135: 1-10.
11. Sasaki T, Tsubakishita S, Tanaka Y et al. Multiplex-PCR method for species identification of coagulase-positive staphylococci. J Clin Microbiol 2010; 48: 765-769.
12. Kawakami T, Shibata S, Murayama N et al. Antimicrobial susceptibility and methicillin resistance in Staphylococcus pseudintermedius and Staphylococcus schleiferi subsp. coagulans isolated from dogs with pyoderma. J Vet Med Sci 2010; 72: 1615-1619.
13. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals; Approved Standard, 3rd edition. CLSI document M31-A3 Wayne, PA: CLSI, 2008.
14. Papich MG. Proposed changes to clinical laboratory standards institute interpretive criteria for methicillin-resistant Staphylococcus pseudintermedius isolated from dogs. J Vet Diagn Invest 2010; 22: 160.
15. Rouch DA, Cram DS, DiBerardino D et al. Efflux-mediated antiseptic gene qacA from Staphylococcus aureus: common ancestry with tetracycline- and sugar-transport proteins. Mol Microbiol 1990; 4: 2051-2062.
16. Sasatsu M, Shima K, Shibata Y et al. Nucleotide sequence of a gene that encodes resistance to ethidium bromide from a transferable plasmid in Staphylococcus aureus. Nucleic Acids Res 1989; 17: 10103.
17. Tsuchizaki N, Ishikawa J, Hotta K. Colony PCR for rapid detection of antibiotic resistance genes in MRSA and enterococci. Jpn J Antibiot 2000; 53: 422-439.
18. Mayer S, Boos M, Beyer A et al. Distribution of the antiseptic resistance gene qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus. J Antimicrob Chemother 2001; 47: 893-905.
19. Smith K, Gemmell CG, Hunter IS. The association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolates. J Antimicrob Chemother 2008; 61: 78-84.
20. Anthonisen IL, Sunde M, Steinum TM et al. Organization of antiseptic resistance gene qacA and Tn552-related β-lactamase gene in multidrug-resistance Staphylococcus haemolyticus strains of animal and human origins. Antimicrob Agents Chemother 2002; 46: 3606-3612.
21. Bjorland J, Steinum T, Kvitle B et al. Widespread distribution of disinfectant resistance genes among Staphylococci of bovine and caprine origin in Norway. J Clin Microbiol 2005; 43: 4363-4368.
22. Bjorland J, Steinum T, Sunde M et al. Novel plasmid-borne gene qacJ mediates resistance to quaternary ammonium compounds in equine Staphylococcus aureus, Staphylococcus simulans, and Staphylococcus intermedius. Antimicrob Agents Chemother 2003; 47: 3046-3052.
23. Bjorland J, Sunde M, Waage S. Plasmid-borne smr gene causes resistance to quaternary ammonium compounds in bovine Staphylococcus aureus. J Clin Microbiol 2001; 39: 3999-4004.
24. Lambert RJW. Comparative analysis of antibiotic and antimicrobial biocide susceptibility data in clinical isolates on methicillin-sensitive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Pseudomonas aerginosa between 1989 and 2000. J Appl Microbiol 2004; 97: 699-711.
25. Sheng WH, Wang JT, Laderdale TL et al. Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Taiwan: emphasis on chlorhexidine susceptibility. Diagn Microbiol Infect Dis 2009; 63: 309-313.
26. Koburger T, Hübner NO, Braun M et al. Standard comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. J Antimicrob Chemother 2010; 65: 1712-1719.
27. Loeffler A, Cobb MA, Bond R. Comparison of a chlorhexidine and benzoyl peroxide shampoo as sole treatment in canine superficial pyoderma. Vet Rec 2011; 169: 249-253.
28. Karpanen TJ, Worthington T, Conway BR et al. Penetration of chlorhexidine into human skin. Antimicrob Agents Chemother 2008; 52: 3633-3636.
29. Akiyama H, Ueda M, Kanazaki H et al. Biofilm formation of Staphylococcus aureus strains isolated from impetigo and furuncle: role of fibrinogen and fibrin. J Dermatol Sci 1997; 16: 2-10.
30. Xing M, Shen F, Liu L et al. Antimicrobial efficacy of the alkaloid harmaline alone and in combination with chlorhexidine digluconate against clinical isolates of Staphylococcus aureus grown in planktonic and biofilm cultures. Lett Appl Microbiol 2012; 54: 475-482.
31. Osland AM, Vestby LK, Fanuelsen H et al. Clonal diversity and biofilm-forming ability of methicillin-resistant Staphylococcus pseudintermedius. J Antimicrob Chemother 2012; 67: 841-848.
32. Pitten F-A, Werner H-P, Kramer A. A standardized test to assess the impact of different organic challenges on the antimicrobial activity of antiseptics. J Hosp Infect 2003; 55: 108-115.
33. Rosenkrantz WS. Shampoo therapy. In: Bonagura JD, Twedt DC, eds. Kirk's Current Veterinary Therapy XIV. St Louis: Saunders Elsevier, 2009; 410-415.